申请人:Gruenenthal GmbH
公开号:US07893069B2
公开(公告)日:2011-02-22
Substituted imidazo[2,1-b]thiazole compounds corresponding to formula I,
a method for producing them, pharmaceutical compositions containing them, and the use thereof for regularing mGluR5 receptors, or for treating or inhibiting disorders or disease states at least partially mediated by mGluR5 receptor such as pain, anxiety attacks, drug or alcohol dependency, and others.
本发明涉及一种对应于公式I的取代咪唑[2,1-b]噻唑化合物,一种制备它们的方法,含有它们的药物组合物以及将其用于调节mGluR5受体或用于治疗或抑制至少部分由mGluR5受体介导的疾病或疾病状态,例如疼痛,焦虑发作,药物或酒精依赖等。